cro.directory
← Compare landing

Accelera Srl vs Genevoyager (Wuhan) Co., Ltd.

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAccelera SrlGenevoyager (Wuhan) Co., Ltd.
SummaryEurope-based preclinical CRO specializing in GLP-compliant toxicology, safety assessment, and efficacy testing for small molecules and biologics, with AAALAC accreditation and integrated translational research capabilities.Leading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.
Services
  • Safety Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • GLP Toxicology
  • DART (Reproductive & Developmental Toxicology)
  • Regulatory Affairs
  • Translational Research
  • Regulatory Affairs
  • Analytical Method Development & Validation
  • Translational Research
Modalities
  • Small Molecule
  • Biologics (Other)
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
Indications
  • Oncology
Data not yet provided.
Phases
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Preclinical (General)
  • Preclinical (IND-Enabling)
Sourcing models
  • Full-Service Outsourcing (FSO)
  • Full-Service Outsourcing (FSO)
Locations
  • Headquarters, Milan, Italy
  • Headquarters & cGMP Facility, Wuhan, Jiangxia District, China
Certifications
  • AAALAC · Identifier: AAALAC accreditation
  • GLP · Identifier: GLP compliance
  • China · Identifier: High-tech Enterprise (高新技术企业)

Find similar companies

Accelera Srl alternatives · Genevoyager (Wuhan) Co., Ltd. alternatives

Markdown mirror: /compare/accelera/genevoyager-2.md